Lowering drug prices: will the cost outweigh the cure?
Experts at Wharton and Drexel analyze whether lowered prescription drug costs will be damaging to future drug research and manufacturing, and what is more important in the short and long-term for patients.
FULL STORY AT Knowledge at Wharton →